Medical app publisher Epocrates went public this morning. Along with its selling stockholders, Epocrates raised more than expected: $86.4 million before costs. This is Epocrates third IPO attempt: In 2008 it filed for a $75 million IPO, but withdrew it because of the economic downturn. Last summer Epocrates filed for another $75 million IPO.
Apparently, being patient paid off.
The newest publicly...
Epocrates, a popular provider of mobile drug reference tools, has re-filed for an estimated $75 million initial public offering, that will see its shares traded on NASDAQ under the symbol EPOC. Epocrates plans to use proceeds from the IPO for working capital, research and development, sales and marketing and capital expenditures, according to a filing with the SEC. Epocrates filed similar $75...
